The federal suit filed in Massachusetts accuses drug makers Sanofi, Novo Nordisk and Eli Lilly of raising the list prices of their products “in perfect lock step” for years.
The accusations center on the shadowy rebate system between drug makers and pharmacy benefit managers, which this news outlet has been investigating.
Read more about the lawsuit: Insulin makers accused of price-fixing scheme
More from our investigation:
In Other News
1
National Air Force Museum prepares eclipse event for up to 30K
2
Indian Lake State Park reopens Friday after tornado, storms
3
Lebanon approves use of automatic license plate readers
4
Ohio to purchase ‘shoot houses’ to train armed school employees
5
Dorothy Lane Market to close for 30 minutes during eclipse
About the Author